ArticleThe patient2021

High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.

Jorge Maurino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.